Basket cover image
15 handpicked stocks

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated today | Published at août 19

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

PCTY

Paylocity Holding Corporation

PCTY

Current price

$178.18

Leading provider of HR and workforce management solutions positioned to benefit from increased compliance spending.

LAW

CS DISCO LLC

LAW

Current price

$3.79

Specialises in legal compliance technology and services essential for modern workforce management.

TNET

TriNet Group, Inc.

TNET

Current price

$65.59

Provides critical HR technology infrastructure that helps businesses maintain compliant labour practices.

About This Group of Stocks

1

Our Expert Thinking

The Qantas ruling represents a watershed moment for corporate accountability. With a record £58 million fine for unlawful dismissals, businesses worldwide are realising that labour law violations carry severe financial consequences. This creates a compelling investment opportunity in companies that provide the essential HR and compliance infrastructure modern businesses desperately need.

2

What You Need to Know

This group focuses on established players in HR technology, legal compliance services, and workforce management solutions. These companies are positioned to benefit from increased corporate spending on compliance infrastructure as businesses seek to avoid costly penalties. The theme represents a tactical growth opportunity driven by regulatory enforcement rather than speculative trends.

3

Why These Stocks

Each company in this selection provides essential services that help businesses navigate complex labour laws and maintain compliant workforce practices. These aren't random picks - they're carefully chosen providers of HR software, legal compliance tools, and ethical oversight technologies that corporations will increasingly rely on to protect themselves from regulatory penalties.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+28.36%

Group Performance Snapshot

28.36%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 28.36% over the next year.

12 of 15

Stocks Rated Buy by Analysts

12 of 15 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

⚖️

Legal Precedent Set

The Qantas ruling establishes that labour law violations carry severe financial consequences. Companies providing compliance solutions are positioned to benefit as businesses scramble to strengthen their practices.

💰

Compliance Spending Surge

With £58 million fines now a reality, corporate spending on HR and compliance technology is set to accelerate. These companies offer the essential infrastructure businesses need to avoid costly penalties.

🎯

Clear Market Catalyst

This isn't speculative investing - it's a tactical opportunity driven by regulatory enforcement. The Qantas case creates immediate demand for the services these companies provide.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
Big Tech's Nuclear Bet: Powering The AI Revolution

Big Tech's Nuclear Bet: Powering The AI Revolution

Google's partnership to build a small modular nuclear reactor highlights a pivotal shift in powering AI infrastructure. This theme focuses on the companies enabling the next generation of nuclear energy to meet Big Tech's surging electricity demands.

View stocks
View All Stock Groups

Frequently Asked Questions

Everything you need to know about the product and billing.